###begin article-title 0
###xml 95 103 <span type="species:ncbi:9606">Patients</span>
Molecular Analysis of Activation-Induced Cytidine Deaminase Gene in Immunoglobulin-E Deficient Patients
###end article-title 0
###begin p 1
Recommended by Kurt Blaser
###end p 1
###begin p 2
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 600 605 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 801 806 801 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
Understanding how class switch recombination (CSR) is regulated to produce immunoglobulin E (IgE) has become fundamental because of the dramatic increase in the prevalence of IgE-mediated hypersensitivity reactions. CSR requires the induction of the enzyme AICDA in B cells. Mutations in AICDA have been linked to Hyper-IgM syndrome (HIGM2), which shows absence of switching to IgE as well as to IgG and IgA. Although isolated IgE deficiency is a rare entity, here we show some individuals with normal serum IgM, IgG, and IgA levels that had undetectable total serum IgE levels. We have analyzed the AICDA gene in these individuals to determine if there are mutations in AICDA that could lead to selective IgE deficiency. Conformational sensitive gel electrophoresis (CSGE) and sequencing analysis of AICDA coding sequences demonstrated sequence heterogeneity due to 5923A/G and 7888C/T polymorphisms, but did not reveal any novel mutation that might explain the selective IgE deficit.
###end p 3
###begin title 4
1. INTRODUCTION
###end title 4
###begin p 5
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 431 432 431 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 716 718 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 752 754 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 794 799 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#947;</italic>
###xml 801 808 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;</italic>
###xml 813 818 801 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 1106 1107 1090 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 1109 1110 1093 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 1313 1314 1297 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1315 1316 1299 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
The prevalence of immunoglobulin-E-(IgE-) mediated hypersensitivity reactions, such as allergic asthma, rhinitis, hay fever, or food allergy, has been dramatically increasing for the last decades [1]. Total serum IgE levels tend to be higher in allergic patients compared with nonallergic individuals, although the diagnostic value of total serum IgE is limited [2] and the presence of specific IgE is not always equal to disease [3, 4]. The effectiveness of humoral immune responses depends on the capacity of B-cells to class switch from IgM to the other downstream isotypes. Class switch recombination (CSR) is a recombinational process that requires the introduction of double-stranded DNA breaks into the donor mu switch region, that is 5' to the mu constant regions, and into a recipient gamma, epsilon, or alpha switch region that is 5' to each of those constant regions. The antibody repertoire is shaped not only by CSR, but also by somatic hypermutation (SHM) to create higher affinity antibodies. Both processes occur in centroblast B cells in the germinal centers of secondary lymphoid organs [5, 6]. A major break through in the understanding of how these processes are initiated was provided by the discovery of the mutagenic enzyme activation-induced cytidine deaminase (AICDA, also known as AID) [7-9].
###end p 5
###begin p 6
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 443 448 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 640 645 640 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 793 798 793 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
Class switching to IgE requires two signals: the first is delivered by IL-4 and IL-13, and the second is provided by the interaction of the B-cell surface antigen CD40 with its ligand CD154 (CD40L) [10], which is transiently expressed on activated T cells and synergizes with IL-4 to induce AICDA-encoding messenger RNA and AICDA protein [11]. When initiating IgE switching, IL-4 induces the binding of STAT6 to a site in the 5' region of the AICDA gene, and CD40 activation induces the binding of NF-kB to two sites in the same region of the AICDA gene [12]. Synergy between IL-4 and CD40 might be required to achieve a threshold level of AICDA expression for CSR to IgE [13]. Several groups have reported an association between serum IgE levels, allergic disorders, and polymorphisms in the AICDA gene [14-16], although this association is not completely understood and might vary among populations [17, 18].
###end p 6
###begin p 7
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1041 1046 1041 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
Defects in CSR have been described in hyperimmunoglobulin M (IgM) syndromes, which are primary immunodeficiencies characterized by normal or elevated serum IgM levels with the absence of other isotypes [19]. A group of patients with the autosomal recessive form of the hyper-IgM syndrome (HIGM2) are known to have mutations in the AICDA gene [7, 20]. Since some of these mutations in AICDA are not in its active site, it has been assumed that they related to the targeting of AICDA. This is born out by the fact that mutations and deletions in the C-terminal region of AICDA result in the loss of class switching while SHM persists [21, 22], whereas mutations in the N-terminal part of AICDA lead to the loss of SHM and retention of CSR [23]. This suggests that there may be AICDA associated proteins that are required for the targeting to switch regions and raises the possibility that different proteins associate with AICDA to target it to each of the switch regions. One way to screen for such interactions is to search for mutations in AICDA that lead to selective CSR impairment in clinical groups with specific immunodeficiencies.
###end p 7
###begin p 8
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
Isolated IgE deficiency is a rare entity and its association to clinical relevant immunodeficiency is controversial [24-29]. As opposed to hyper-IgM syndromes, the levels of other isotypes are normal in individuals with isolated IgE deficiency, suggesting the possibility of a selective CSR defect to this isotype. In the present study, we had the opportunity to investigate a rare group of 9 individuals with isolated IgE deficiency. In an attempt to further understand the contributions of AICDA to the mechanisms underlying CSR and IgE production, we performed a molecular characterization of AICDA gene in these subjects, to assess whether specific defects in AICDA are related to isolated deficiency of total serum IgE levels.
###end p 8
###begin title 9
2. MATERIALS AND METHODS
###end title 9
###begin title 10
2.1. Subjects
###end title 10
###begin p 11
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 999 1015 999 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D. pteronisynuss</italic>
###xml 1017 1027 1017 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D. farinae</italic>
###xml 1029 1042 1029 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. destructor</italic>
###xml 1044 1060 1044 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. putrescentiae</italic>
###xml 1062 1069 1062 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. siro</italic>
###xml 1071 1084 1071 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G. domesticus</italic>
###xml 1086 1095 1086 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. maynei</italic>
###xml 1127 1137 1127 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. judaica</italic>
###xml 1139 1147 1139 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. album</italic>
###xml 1149 1160 1149 1160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. vulgaris</italic>
###xml 1162 1175 1162 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. lanceolata</italic>
###xml 1177 1188 1177 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">O. europaea</italic>
###xml 1190 1202 1190 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. alternata</italic>
###xml 1204 1215 1204 1215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C. herbarum</italic>
###xml 1217 1227 1217 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. notatum</italic>
###xml 1229 1241 1229 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 472 480 <span type="species:ncbi:9606">patients</span>
###xml 665 673 <span type="species:ncbi:9606">patients</span>
###xml 702 710 <span type="species:ncbi:9606">patients</span>
###xml 1017 1027 <span type="species:ncbi:6954">D. farinae</span>
###xml 1029 1042 <span type="species:ncbi:36936">L. destructor</span>
###xml 1044 1060 <span type="species:ncbi:59818">T. putrescentiae</span>
###xml 1062 1069 <span type="species:ncbi:66546">A. siro</span>
###xml 1071 1084 <span type="species:ncbi:105145">G. domesticus</span>
###xml 1086 1095 <span type="species:ncbi:6958">E. maynei</span>
###xml 1127 1137 <span type="species:ncbi:33127">P. judaica</span>
###xml 1139 1147 <span type="species:ncbi:61247|species:ncbi:3559|species:ncbi:199168|species:ncbi:78411|species:ncbi:320031|species:ncbi:300208">C. album</span>
###xml 1149 1160 <span type="species:ncbi:36596|species:ncbi:236853|species:ncbi:4220|species:ncbi:49855|species:ncbi:59638|species:ncbi:3451|species:ncbi:7604|species:ncbi:52918|species:ncbi:338020">A. vulgaris</span>
###xml 1162 1175 <span type="species:ncbi:54947|species:ncbi:182767|species:ncbi:44964|species:ncbi:325544|species:ncbi:58462|species:ncbi:313965|species:ncbi:266371|species:ncbi:86182|species:ncbi:86859|species:ncbi:304150|species:ncbi:43175|species:ncbi:31457|species:ncbi:25385|species:ncbi:273605|species:ncbi:57511|species:ncbi:200738|species:ncbi:253796|species:ncbi:39414|species:ncbi:71093|species:ncbi:109222|species:ncbi:225223|species:ncbi:478193|species:ncbi:383731|species:ncbi:151733">P. lanceolata</span>
###xml 1177 1188 <span type="species:ncbi:4146|species:ncbi:330175|species:ncbi:70651">O. europaea</span>
###xml 1190 1202 <span type="species:ncbi:5599|species:ncbi:95181|species:ncbi:318205">A. alternata</span>
###xml 1204 1215 <span type="species:ncbi:253104|species:ncbi:150122|species:ncbi:180946|species:ncbi:29918">C. herbarum</span>
###xml 1217 1227 <span type="species:ncbi:292861|species:ncbi:147272|species:ncbi:5076">P. notatum</span>
###xml 1229 1241 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 1243 1246 <span type="species:ncbi:9615">dog</span>
###xml 1248 1251 <span type="species:ncbi:9685">cat</span>
###xml 1262 1267 <span type="species:ncbi:9796">horse</span>
###xml 1269 1275 <span type="species:ncbi:9986">rabbit</span>
###xml 1706 1714 <span type="species:ncbi:9606">patients</span>
This study was performed in 9 patients with serum IgE levels below 2 kU/1 selected from a total of 643 patients that were referred during two consecutive years to the Allergy Department of the University Hospital of Salamanca (Spain) for an allergic evaluation. All of them gave informed written consent and the study was performed following the recommendations of the Ethical Committee of the University Hospital of Salamanca. Total serum IgE levels were measured in all patients by fluorescent enzyme immunoassay (ImmunoCAP total IgE, Phadia, Uppsala, Sweden), which exhibits a measuring range for undiluted serum of 2-5000 kU/l. Since IgE levels vary greatly in patients younger than 15 years, only patients older than 18 years were selected. IgE deficiency was defined as a total serum IgE level below 2 kU/l. Skin prick testing was performed following the European Academy of Allergology and Clinical Immunology (EAACI) recommendations [30] with a battery of common aeroallergens that included D. pteronisynuss, D. farinae, L. destructor, T. putrescentiae, A. siro, G. domesticus, E. maynei, mix of grasses, mix of trees, P. judaica, C. album, A. vulgaris, P. lanceolata, O. europaea, A. alternata, C. herbarum, P. notatum, A. fumigatus, dog, cat, hamster, horse, rabbit dander, and cockroach (ALK-Abello, Madrid, Spain). Histamine (10 mg/mL) was used as positive control and saline was used as negative control. Before skin testing, antihistamines were discontinued according to published guidelines. Skin tests were considered positive if at least one wheal reaction of more than 3 mm of diameter after subtraction of the negative control was observed. IgM, IgG, and IgA levels were measured in all patients with IgE level below 2 kU/l, by nephelometry (Dade Behring Inc, Deerfield, Ill, USA).
###end p 11
###begin title 12
2.2. DNA extraction, PCR primers design, and amplification reactions
###end title 12
###begin p 13
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 347 354 347 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 419 421 419 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 434 436 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 452 454 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 529 531 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Genomic DNA was extracted from peripheral blood lymphocytes using a standard phenol-chloroform protocol. Exons 1-5 and intronic flanking sequences of the AICDA gene were amplified using polymerase chain reaction (PCR). 3' ends of all primers were designed to be located at least 45 base pair (bp) away from the splice junctions or the stop codon (Table 1). Amplifications were performed using 250 ng of DNA template, 1 muL of each 10 muM primer and 21 muL of 2xPCR Master Mix (Promega, Madison, Wis, USA) in a final volume of 25 muL in an GeneAmp PCR System9700 automated thermocycler (PE Applied Biosystems, Foster City, Calif, USA) with the same conditions: 4 minutes of denaturation at 94degreesC, followed by 30 cycles with a denaturation step of 1 minute at 94degreesC, an annealing step of 1 minute at 55degreesC, an extension step of 1 minute at 72degreesC, and a final 10 minutes extension at 72degreesC. Amplification of the samples was checked by electrophoresis in 2% agarose gels.
###end p 13
###begin title 14
2.3. Mutation detection by CSGE (conformational sensitive gel electrophoresis)
###end title 14
###begin p 15
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 157 159 157 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 201 203 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
Mutation detection enhancement (MDE) gels (Cambrex, Rockland, Me, USA) were used to analyze PCR products for the presence of mutations in the AICDA gene. 10 muL of the PCR product were combined with 2 muL of 6xTriple dye loading buffer (Cambrex, Rockland, Me, USA). The samples were heated at 95degreesC for 5 minutes, slowly cooled to 37degreesC and run on 0.5xMDE gels containing 0.6xTris-Borate-EDTA (TBE) buffer (1xTBE = 0.089 M Tris-Borate, 0.002 M EDTA, and pH 8.3). Gels were run overnight in 0.6xTBE at 20 V/cm for 12-18 hours, depending on the size of the PCR product. MDE gels were stained using PlusOne DNA silver staining kit (Amersham Biosciences, Uppsala, Sweden) according to the manufacturer's instructions. Heteroduplex bands were visualized on a transilluminator and documented.
###end p 15
###begin title 16
2.4. Sequencing
###end title 16
###begin p 17
###xml 356 363 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
Whenever a heteroduplex was detected, nucleotide sequence information was determined by direct sequencing of the PCR products. The genotyping of intron 2 (5923A/G) and exon 4 (7888C/T) polymorphisms were performed by direct sequencing in all cases. The same primers designed for PCR amplification were used for the sequencing analysis of the PCR products (Table 1). PCRs fragments were purified with MicroSpin S-300 HR Columns (Amersham Biosciences, Piscataway, Nj, USA) and sequenced using d-Rhodamine Dye terminator cycle sequencing kit and analysed with ABI Prism 377 genetic analyser (Applied Biosystems, Inc).
###end p 17
###begin title 18
3. RESULTS
###end title 18
###begin p 19
###xml 202 209 202 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 20 28 <span type="species:ncbi:9606">patients</span>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 226 234 <span type="species:ncbi:9606">patients</span>
From a total of 643 patients that underwent determination of total serum IgE, 9 patients had IgE levels below 2 kU/l (1.4%). Strikingly, total serum IgM, IgG, and IgA levels were normal in all of them (Table 2). None of these patients had personal history of allergy or atopy and all of them had negative skin tests. No previous personal or familial history suggesting immunodeficiency was recorded in any of them. Nevertheless, an increase in nonallergic reactive airway diseases (i.e., nonallergic asthma) and autoimmunity (i.e., hyperthyroidism and dermatomyositis) was observed.
###end p 19
###begin p 20
###xml 72 77 72 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 382 390 382 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
MDE gel electrophoresis of PCR products spanning exons 1, 3, and 5 from AICDA gene revealed germ-line configurations. As expected, due to 5923A/G and 7888C/T polymorphisms [16], several heteroduplex patterns were detected in PCR products spanning exons 2 and 4, respectively. Sequence analysis of both regions in all patients identified different alleles for the polymorphic sites (Figure 1) but did not reveal any novel mutation.
###end p 20
###begin p 21
###xml 200 207 200 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab3">Table 3</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 179 187 <span type="species:ncbi:9606">patients</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
Distributions of genotypes of the 5923A/G and 7888C/T polymorphisms were consistent with Hardy-Weinberg equilibrium. The distribution of genotypes of these polymorphisms in the 9 patients is shown in Table 3. We have studied a small number of patients because of the low prevalence of IgE deficiency. Although this is an important limitation to the study of this condition, the genotype frequencies of the synonymous 7888C/T polymorphism at exon 4 (Reference SNP Identification rs2028373 [31]) did not deviate from expected values previously reported [16, 18]. In the case of the AICDA intronic 5923A/G polymorphism, genotype frequencies were similar to those reported in NCBI single nucleotide polymorphism database, according to Reference SNP Identification rs2518144 [31]. The diplotype distribution of both polymorphisms was heterogeneous. No specific haplotype was detected in this population.
###end p 21
###begin title 22
4. DISCUSSION
###end title 22
###begin p 23
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 908 910 908 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1464 1466 1464 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 468 476 <span type="species:ncbi:9606">patients</span>
###xml 639 647 <span type="species:ncbi:9606">patients</span>
###xml 927 935 <span type="species:ncbi:9606">patients</span>
###xml 1299 1307 <span type="species:ncbi:9606">patients</span>
The level of serum IgE is usually 10,000 to 50,000-fold lower than the level of serum IgG and its production is tightly regulated. The overall role of IgE in immunity is not completely understood, but it seems to be involved in the defence against parasitic infections. Reports about IgE deficiency are limited and their association with clinically relevant immunodeficiency is still controversial [24-29]. We have evaluated the clinical characteristics of a group of patients with serum IgE levels below 2 kU/l, but normal IgM, IgG, and IgA serum levels (Table 2). In our setting of an outpatient allergy clinic, only 9 out of 643 (1.4%) patients that underwent IgE determination had serum total IgE levels under the detection threshold (2 kU/l). There is limited information about prevalence of IgE deficits. Levy et al. [32] found an incidence of 16.5%, but their threshold was 10 kU/l, and Smith et al. [29] found 10.5% of patients with IgE levels below 2.5 kU/l. Our incidence is lower probably due to the lower threshold that we used. Although controversial, there are some reports on local IgE production [33] and therefore we cannot absolutely discard the possibility of local CSR to IgE in tissue. Nevertheless we believed that this fact is highly improbable because it has been shown that patients with local production of specific IgE did not have undetectable total IgE levels and they suffered from perennial rhinitis, usually with seasonal symptoms [34].
###end p 23
###begin p 24
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 342 350 <span type="species:ncbi:9606">patients</span>
None of the patients with IgE deficiency included in our series showed personal or familial clinical data of immunodeficiency but three patients presented nonallergic asthma, and autoimmune disorders were present in two patients. This is in agreement with the study of Smith et al. [29], which found a higher prevalence of both conditions in patients with serum IgE levels below 2.5 kU/l, suggesting the existence of common genetic factors that may predispose to both IgE deficiency and autoimmunity. Other authors have proposed that deregulation of molecules and signals that play a key role in B-cell activation and terminal differentiation could be involved in initiating or maintaining autoimmunity [35].
###end p 24
###begin p 25
###xml 86 87 86 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 290 295 290 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1030 1035 1030 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 1291 1296 1291 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 1325 1330 1325 1330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 1504 1509 1504 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 1938 1946 1938 1940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949; </italic>
###xml 80 84 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
###xml 937 945 <span type="species:ncbi:9606">patients</span>
###xml 1086 1094 <span type="species:ncbi:9606">patients</span>
AICDA plays an essential role in CSR, which is impaired in both AICDA-deficient mice [8] and in patients with HIGM2 syndrome [7, 20]. An association between serum IgE levels and AICDA has been previously reported, and several studies have shown the association between polymorphisms in the AICDA gene and allergic disorders [14-16], although this association is not completely understood and might vary among populations [17, 18]. Serum IgE levels have an inherited non-Mendelian component, although there is one report that showed an autosomal dominant pattern with a variable degree of penetrance in patients with IgE deficiency [28]. Exploration of genetic regulation in IgE responses, based on both candidate gene approaches and linkage studies has led to the report of several sets of molecular and cellular interactions that are essential for IgE synthesis [36]. Nevertheless, no study of susceptibility loci has been performed on patients with undetectable serum IgE levels. Here, we have examined whether mutations in the AICDA gene might explain the phenotype of our cohort of patients with isolated IgE deficiency and affect the specificity of switching towards IgE production. We have identified two previously described polymorphisms (intron 2 5923A/G and exon 4 7888C/T) in the AICDA gene, but no defects in the AICDA coding or flanking regions account for the IgE deficit in our cohort. Previous reports and public databases on these polymorphisms did not show any evident association with AICDA expression levels, splicing or function. We cannot rule out that mutations in the promoter region, epigenetic changes or posttranslational modifications in AICDA could be involved in the decrease of IgE levels. In addition, other factors involved in immunoglobulin class switching besides AICDA might be implicated. The characterization of such factors would be important in understanding the specific targeting of AICDA to the epsilon  switch region and the molecular basis of isolated IgE deficiency.
###end p 25
###begin title 26
5. CONCLUSIONS
###end title 26
###begin p 27
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 675 680 675 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 244 252 <span type="species:ncbi:9606">patients</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
The exploration of various types of clinical immunodeficiencies provides a unique opportunity to better understand the molecular basis of immunoglobulin class switch recombination. Here, we evaluated the clinical characteristics of a cohort of patients with isolated IgE deficiency, which exhibited a higher prevalence of nonallergic asthma and autoimmunity disorders. We analyzed AICDA, the master gene required for CSR, in these patients to see if there were specific mutations that would result in impaired CSR and explain their undetectable serum IgE levels. Two previously described polymorphisms (intron 2 5923A/G and exon 4 7888C/T), but no mutation, were detected in AICDA gene. Further search for alternative causes of isolated IgE deficiency could open new ways to understand specific CSR and IgE production.
###end p 27
###begin title 28
ACKNOWLEDGMENTS
###end title 28
###begin p 29
The authors are indebted to Mrs. Nieves Mateos for her technical help. The authors thank Dr. Matthew D. Scharff for his helpful discussions and critical reading of the manuscript. This work was supported by Fundacion MMA and Junta de Castilla y Leon (Grant no. SA090/01).
###end p 29
###begin article-title 30
Triggers of IgE class switching and allergy development
###end article-title 30
###begin article-title 31
Problems in defining normal limits for serum IgE
###end article-title 31
###begin article-title 32
Asymptomatic skin sensitization to birch predicts later development of birch pollen allergy in adults: a 3-year follow-up study
###end article-title 32
###begin article-title 33
Prognostic value of asymptomatic skin sensitization to aeroallergens
###end article-title 33
###begin article-title 34
Activation-induced cytidine deaminase: a dual role in class-switch recombination and somatic hypermutation
###end article-title 34
###begin article-title 35
Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation
###end article-title 35
###begin article-title 36
Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)
###end article-title 36
###begin article-title 37
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
###end article-title 37
###begin article-title 38
The biochemistry of somatic hypermutation
###end article-title 38
###begin article-title 39
Immunoglobulin E and its regulators
###end article-title 39
###begin article-title 40
The regulation of immunoglobulin E class-switch recombination
###end article-title 40
###begin article-title 41
###xml 121 126 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
Induction of activation-induced cytidine deaminase gene expression by IL-4 and CD40 ligation is dependent on STAT6 and NFkappaB
###end article-title 41
###begin article-title 42
###xml 45 50 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#954;</italic>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Cooperation of binding sites for STAT6 and NFkappaB/rel in the IL-4-induced up-regulation of the human IgE germline promoter
###end article-title 42
###begin article-title 43
###xml 28 33 28 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
Polymorphisms of IL-4, IL-4Ralpha, and AICDA genes in adult allergic asthma
###end article-title 43
###begin article-title 44
Correlation between activation-induced cytidine deaminase gene polymorphism and atopic asthma and plasma IgE in adult
###end article-title 44
###begin article-title 45
Association between a new polymorphism in the activation-induced cytidine deaminase gene and atopic asthma and the regulation of total serum IgE levels
###end article-title 45
###begin article-title 46
Linkage and association of childhood asthma with the chromosome 12 genes
###end article-title 46
###begin article-title 47
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AID</italic>
Lack of association between the 7888 C/T polymorphism in the AID gene and atopy in a Spanish population
###end article-title 47
###begin article-title 48
Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies
###end article-title 48
###begin article-title 49
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Analysis of class switch recombination and somatic hypermutation in patients affected with autosomal dominant hyper-IgM syndrome type 2
###end article-title 49
###begin article-title 50
C-terminal deletion of AID uncouples class switch recombination from somatic hypermutation and gene conversion
###end article-title 50
###begin article-title 51
AID mutant analyses indicate requirement for class-switch-specific cofactors
###end article-title 51
###begin article-title 52
Separate domains of AID are required for somatic hypermutation and class-switch recombination
###end article-title 52
###begin article-title 53
###xml 22 28 <span type="species:ncbi:9606">person</span>
Healthy IgE-deficient person
###end article-title 53
###begin article-title 54
###xml 22 28 <span type="species:ncbi:9606">person</span>
Healthy IgE-deficient person
###end article-title 54
###begin article-title 55
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Immunoglobulin E in immunologic deficiency diseases. II. Serum IgE concentration of patients with acquired hypogammaglobulinemia, thymoma and hypogammaglobulinemia, myotonic dystrophy, intestinal lymphangiectasia and Wiskott-Aldrich syndrome
###end article-title 55
###begin article-title 56
Immunoglobulin E in immunologic deficiency diseases. I. Relation of IgE and IgA to respiratory tract disease in isolated IgE deficiency, IgA deficiency, and ataxia telangiectasia
###end article-title 56
###begin article-title 57
Familial IgE deficiency associated with sinopulmonary disease
###end article-title 57
###begin article-title 58
Clinical manifestations of IgE hypogammaglobulinemia
###end article-title 58
###begin article-title 59
Position paper: allergen standardization and skin tests. The European Academy of Allergology and Clinical Immunology
###end article-title 59
###begin article-title 60
dbSNP: the NCBI database of genetic variation
###end article-title 60
###begin article-title 61
The association of selective IgA deficiency and IgE hypogammaglobulinemia
###end article-title 61
###begin article-title 62
###xml 60 68 <span type="species:ncbi:9606">patients</span>
Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis
###end article-title 62
###begin article-title 63
Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response
###end article-title 63
###begin article-title 64
Hyper IgM syndromes
###end article-title 64
###begin article-title 65
Genetic regulation of IgE responses: achilles and the tortoise
###end article-title 65
###begin p 66
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Sequencing analysis of regions 2 and 4 from human AICDA gene, where genetic variants were detected by heteroduplex. Panels show sequences of the different alleles corresponding to 5923A/G polymorphism at the 3'-flanking region of (a) exon 2 and 7888C/T polymorphism at (b) exon 4 of the AICDA gene. Arrows indicate the polymorphic sites.
###end p 66
###begin p 67
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
AICDA primers, PCR conditions, and size of the fragments used in the study.
###end p 67
###begin p 68
*Position of primers is according to GENBANK sequence Accession Number AB040430.1.
###end p 68
###begin p 69
###xml 29 37 <span type="species:ncbi:9606">patients</span>
Phenotype characteristics of patients with IgE hypogammaglobulinemia.
###end p 69
###begin p 70
F: female, M: male.
###end p 70
###begin p 71
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AICDA</italic>
Genotype distribution of 5923A/G and 7888C/T polymorphisms from AICDA gene in our population.
###end p 71

